Literature DB >> 32788112

ALK/ROS1 rearrangements: A real hallmark for thromboembolic events in cancer patients?

Federico Nichetti1, Giuseppe Lo Russo2, Arsela Prelaj2, Leonardo Provenzano2, Filippo de Braud3, Mary Cabiddu4, Marina Chiara Garassino2, Fausto Petrelli4.   

Abstract

Entities:  

Keywords:  ALK; Non-Small-Cell Lung Cancer; ROS-1; Thromboembolic events; Thrombosis; Tyrosine kinase inhibitors

Mesh:

Substances:

Year:  2020        PMID: 32788112     DOI: 10.1016/j.thromres.2020.06.041

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  2 in total

1.  Driver Genes Associated With the Incidence of Venous Thromboembolism in Patients With Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Authors:  Xiaohan Qian; Mengjiao Fu; Jing Zheng; Jianya Zhou; Jianying Zhou
Journal:  Front Oncol       Date:  2021-04-29       Impact factor: 6.244

2.  Risk assessment of thromboembolic events in hospitalized cancer patients.

Authors:  Federico Nichetti; Francesca Ligorio; Giulia Montelatici; Luca Porcu; Emma Zattarin; Leonardo Provenzano; Andrea Franza; Luca Lalli; Filippo de Braud; Marco Platania
Journal:  Sci Rep       Date:  2021-09-14       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.